046. COVID-19: Special Populations: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Special Populations

(474) Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting